Additionally, SOX11 promotes PAX5 expression, which in turn blocks plasmacytic differentiation, locking the cell in the mature B-cell stage, and has been previously implicated as an oncogenic mechanism in other B-cell lymphomas (26–28). Here, SOX11 is linked to B-cell non-Hodgkin lymphoma.